153 related articles for article (PubMed ID: 8104536)
1. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma.
Offit K; Parsa NZ; Gaidano G; Filippa DA; Louie D; Pan D; Jhanwar SC; Dalla-Favera R; Chaganti RS
Blood; 1993 Oct; 82(7):2157-62. PubMed ID: 8104536
[TBL] [Abstract][Full Text] [Related]
2. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma.
Gaidano G; Hauptschein RS; Parsa NZ; Offit K; Rao PH; Lenoir G; Knowles DM; Chaganti RS; Dalla-Favera R
Blood; 1992 Oct; 80(7):1781-7. PubMed ID: 1356511
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic evolution patterns in non-Hodgkin's lymphoma.
Johansson B; Mertens F; Mitelman F
Blood; 1995 Nov; 86(10):3905-14. PubMed ID: 7579360
[TBL] [Abstract][Full Text] [Related]
4. Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23).
Offit K; Louie DC; Parsa NZ; Filippa D; Gangi M; Siebert R; Chaganti RS
Blood; 1994 May; 83(9):2611-8. PubMed ID: 8167342
[TBL] [Abstract][Full Text] [Related]
5. Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma.
Offit K; Parsa NZ; Jhanwar SC; Filippa D; Wachtel M; Chaganti RS
Genes Chromosomes Cancer; 1993 May; 7(1):1-7. PubMed ID: 7688550
[TBL] [Abstract][Full Text] [Related]
6. 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas.
Merup M; Moreno TC; Heyman M; Rönnberg K; Grandér D; Detlofsson R; Rasool O; Liu Y; Söderhäll S; Juliusson G; Gahrton G; Einhorn S
Blood; 1998 May; 91(9):3397-400. PubMed ID: 9558398
[TBL] [Abstract][Full Text] [Related]
7. Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies.
Whang-Peng J; Knutsen T; Jaffe ES; Steinberg SM; Raffeld M; Zhao WP; Duffey P; Condron K; Yano T; Longo DL
Blood; 1995 Jan; 85(1):203-16. PubMed ID: 7803794
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment.
Offit K; Jhanwar SC; Ladanyi M; Filippa DA; Chaganti RS
Genes Chromosomes Cancer; 1991 May; 3(3):189-201. PubMed ID: 1868033
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: non-random chromosomal abnormalities and histological correlations.
Juneja S; Lukeis R; Tan L; Cooper I; Szelag G; Parkin JD; Ironside P; Garson OM
Br J Haematol; 1990 Oct; 76(2):231-7. PubMed ID: 2094325
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities involving chromosome 6 in newly diagnosed patients with non-Hodgkin's lymphoma. Nebraska Lymphoma Study Group.
Schouten HC; Sanger WG; Weisenburger DD; Armitage JO
Cancer Genet Cytogenet; 1990 Jul; 47(1):73-82. PubMed ID: 2357689
[TBL] [Abstract][Full Text] [Related]
11. Common region of deletion on the long arm of chromosome 6 in non-Hodgkin's lymphoma and acute lymphoblastic leukaemia.
Menasce LP; Orphanos V; Santibanez-Koref M; Boyle JM; Harrison CJ
Genes Chromosomes Cancer; 1994 Aug; 10(4):286-8. PubMed ID: 7522544
[TBL] [Abstract][Full Text] [Related]
12. Association of 6q deletions with AIDS-related diffuse large cell lymphoma.
Pastore C; Carbone A; Gloghini A; Volpe G; Saglio G; Gaidano G
Leukemia; 1996 Jun; 10(6):1051-3. PubMed ID: 8667642
[TBL] [Abstract][Full Text] [Related]
13. Chromosome band 6q deletion pattern in malignant lymphomas.
Taborelli M; Tibiletti MG; Martin V; Pozzi B; Bertoni F; Capella C
Cancer Genet Cytogenet; 2006 Mar; 165(2):106-13. PubMed ID: 16527604
[TBL] [Abstract][Full Text] [Related]
14. Clonal cytogenetic abnormalities in Hodgkin's disease.
Ladanyi M; Parsa NZ; Offit K; Wachtel MS; Filippa DA; Jhanwar SC
Genes Chromosomes Cancer; 1991 Jul; 3(4):294-9. PubMed ID: 1958594
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetics of non-Hodgkin's lymphoma.
Levine EG; Bloomfield CD
J Natl Cancer Inst Monogr; 1990; (10):7-12. PubMed ID: 2189479
[TBL] [Abstract][Full Text] [Related]
16. t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation.
Offit K; Parsa NZ; Filippa D; Jhanwar SC; Chaganti RS
Blood; 1992 Nov; 80(10):2594-9. PubMed ID: 1384792
[TBL] [Abstract][Full Text] [Related]
17. A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization.
Zhang Y; Matthiesen P; Harder S; Siebert R; Castoldi G; Calasanz MJ; Wong KF; Rosenwald A; Ott G; Atkin NB; Schlegelberger B
Genes Chromosomes Cancer; 2000 Jan; 27(1):52-8. PubMed ID: 10564586
[TBL] [Abstract][Full Text] [Related]
18. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI
Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637
[TBL] [Abstract][Full Text] [Related]
19. Deletions and rearrangement of CDKN2 in lymphoid malignancy.
Stranks G; Height SE; Mitchell P; Jadayel D; Yuille MA; De Lord C; Clutterbuck RD; Treleaven JG; Powles RL; Nacheva E
Blood; 1995 Feb; 85(4):893-901. PubMed ID: 7849311
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations.
Offit K; Wong G; Filippa DA; Tao Y; Chaganti RS
Blood; 1991 Apr; 77(7):1508-15. PubMed ID: 2009370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
